Ruiz-Reyes G, Ruiz-Argüelles GJ, Guzmán O, Ruiz-Argüelles A

Language: English
References: 16
Page: 141-145
PDF size: 64.38 Kb.

ABSTRACT

Background: The definite diagnosis of thalassemia is based upon relatively complex laboratory tests, hence, these syndromes might be underestimated in the routine clinical setting.
Methods: 500 consecutive individuals identified in Laboratorios Clínicos de Puebla with red blood cells showing either hypochromia (MCH‹24 pg) and/or microcytosis (MCV ‹75 fl in women or ‹80 fl in man), with or without anemia, were prospectively accrued in this study, along a 16 month-period. Iron deficiency, β and α-thalassemia were searched by definite methods.
Results: Out of the 500 consecutive cases with red blood cell hypochromia or microcytosis, 394 (78.8%) were found to have iron deficiency, 37 cases had β-thalassemia, 11 cases had a-thalassemia, while in 58 cases (11.6%) a definite diagnosis could not be established. Red cell distribution width (RDW) was significantly lower in the thalassemic patients than in the iron deficient group, and it proved to bear high nosographic sensitivity and specificity for the diagnosis of either α or β thalassemia.
Conclusions: The thalassemic syndromes should be suspected in individuals with red blood cell microcytosis and/or hypochromia, with or without anemia, showing very low RDW values. These individuals should be further tested for thalassemia.

REFERENCES

1. Ruiz-Reyes G. Hemoglobinopatías y talasemias. In: Ruiz-Argüelles GJ (editor). Fundamentos de Hematología. 3a ed. México: Médica Panamericana, 2003;p:132-154.

2. Lukens JN. The thalassemias and related disorders: Quantitative disorders of hemoglobin synthesis. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM (eds). Wintrobe´s Clinical Hematology. 10th ed. Baltimore: Williams & Wilkins, 1999;p:1405-1448.

3. Ruiz-Reyes G.: Abnormal hemoglobins and thalassemia in México. Rev Invest Clín Méx 1998; 50:163-170.

4. Ruiz-Argüelles GJ, López-Martínez B, Ruiz-Reyes G. Heterozygous beta-thalassemia: Not infrequent in México. Arch Med Res 2001;32:293-295.

5. Reyes-Cruz G, Ruiz-Reyes G, Hernández-Acasiete M. Identificación de un foco de talasemia beta en Tamiahua, Veracruz. Rev Invest Clín Méx 1990;42:189-192.

6. Lisker R, Ruiz-Reyes G, López G, Peral-López AM, Zárate G. Características hereditarias de la población mexicana. Estudio de una comunidad de origen italiano. Rev Invest Clín Méx 1966; 18:11-21.

7. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, 1989.

8. Baysal E, Huisman THJ. Detection of common deletional alpha-thalassemia-2 determinants by PCR. Am J Hematol 1994;46:208-213.

9. Reyes-Núñez V, Garcés-Eisele J, Jorge S, Kimura E, et al. Molecular Characterization of Alpha-thalassemia in the Mexican Population. Rev Invest Clin (in press).

10. Bergstrome-Jones AK, Poon A. Evaluation of a single-tube multiplex polymerase chain reaction screen for detection of common alpha-thalassemia genotypes in a clinical laboratory. Am J Clin Pathol 2002;118:18-24.

11. Tan ASC, Quah C, Low PS, Chong SS. A Rapid and Reliable 7-Deletion Multiplex Polymerase Chain Reaction Assay for a-Thalassemia. Blood 2001;98:250-251.

12. Kattamis AC, Camaschella C, Sivera P, Surrey S, Fortina P. Human alpha-thalassemia syndromes: detection of molecular defects. Am J Hematol 1996;53:81-91.

13. Dode C, Rochette J, Krishnamoorthy R. Locus assignment of human alpha globin mutations by selective amplification and direct sequencing. Br J Haematol 1990;76:275-281.

14. Ruiz-Argüelles GJ, Ramírez-Cisneros F, Rivadeneyra L, Ruiz-Delgado MA, Molina-Alavez A. La frecuencia de las anemias megaloblásticas en la práctica privada en Puebla, México: Experiencia de 17 años. Medicina Univ 1999;1:165-167.

15. Ruiz-Reyes G. Los síndromes talasémicos no son infrecuentes en la población mexicana y se subdiagnostican y confunden con deficiencias de hierro. Medicina Univ 1999;1:67-73.

16. Beutler E. The common anemias. J Am Med Assoc 1988; 259:2433-2437.